Mental Health
|
December 26, 2024

Major Depressive Disorder: A Guide to Understanding and Treatment Options

Written By
Dr. Kaylan Jackson Ph.D.
Medically Reviewed by
Updated On
January 8, 2025

Did you know that over 280 million people worldwide live with major depressive disorder (MDD) every day? This condition not only affects mental health but also influences relationships, work, and overall quality of life. MDD is common, yet many people don’t fully understand it. What exactly is it, and how can it be treated?

Major depressive disorder is a serious yet common mental health condition characterized by persistent sadness, a lack of interest in daily activities, and difficulty functioning. The good news? Various treatment options are available. 

This article provides an overview of evidence-based approaches that may help you manage your mental health or help someone you care about.

[signup]

Understanding Major Depressive Disorder

To understand the impact of MDD, it’s helpful to distinguish this condition from temporary sadness or emotional challenges.

What is Major Depressive Disorder?

MDD is more than just "feeling sad." It’s a clinical diagnosis defined by the DSM-5 as having at least five of the following symptoms nearly every day for two weeks:

  • Persistent low mood or sadness.
  • Loss of interest or pleasure in activities (anhedonia).
  • Changes in appetite or weight (increase or decrease).
  • Difficulty sleeping (insomnia) or oversleeping (hypersomnia).
  • Fatigue or low energy that persists throughout the day.
  • Feelings of worthlessness or excessive guilt.
  • Difficulty concentrating or making decisions.
  • Recurrent thoughts of death, suicidal ideation, or suicide attempts.

To qualify as MDD, these symptoms must cause significant distress or impairment in social, occupational, or other important areas of functioning.

Causes and Risk Factors of MDD

MDD is the result of an interplay of several factors, including:

How is it Diagnosed?

Accurate diagnosis requires more than identifying symptoms. Providers must rule out other possible causes, such as bipolar disorder, anxiety disorders, or substance abuse, which often co-occur with depression.

The Diagnostic Process:

  1. Clinical interviews: A healthcare provider asks questions to explore the duration, severity, and triggers of symptoms.
  2. Screening questionnaires: Tools like the PHQ-9 quantify depression severity and track progress.
  3. Lab tests: Thyroid function, vitamin D levels, and iron studies are sometimes ordered to exclude physiological causes.

Prompt diagnosis and early intervention significantly improve treatment outcomes. 

Treatment Options for Major Depressive Disorder

Treatment for MDD often involves a multifaceted approach, with psychotherapy serving as one of the most effective and widely used methods.

Psychotherapy Options

Psychotherapy is a foundational aspect of MDD treatment, offering patients tools to understand and manage their condition. Evidence-based approaches include:

  • Interpersonal Therapy (IPT): IPT focuses on interpersonal relationships and social roles. It’s particularly beneficial for people whose depression stems from unresolved grief, relationship issues, or major life transitions.
  • Dialectical Behavior Therapy (DBT): DBT incorporates mindfulness to manage intense emotions. Techniques like grounding exercises and visualization help individuals navigate moments of crisis without becoming overwhelmed.

Pharmacological Treatments

Medications for MDD are chosen based on factors like symptom severity, medical history, and potential side effects. Adjustments are often made over time to find the right dosage or medication type that effectively alleviates symptoms while minimizing side effects.

Antidepressants are often recommended for individuals with moderate to severe MDD. While they don’t 'cure' depression, they may help address chemical imbalances associated with symptoms.

Antidepressant Classes:

  • Selective serotonin reuptake inhibitors (SSRI): These medications work by increasing serotonin levels in the brain and are typically first-line treatments due to their safety and efficacy.  Name brands include Prozac and Zoloft.
  • Serotonin and norepinephrine reuptake inhibitors (SNRI): These affect both serotonin and norepinephrine, which are crucial for regulating mood and energy. Examples include Cymbalta and Effexor.
  • Atypical antidepressants: By targeting dopamine, these medications can alleviate symptoms like lack of motivation and fatigue. An example is Wellbutrin.

Common Concerns About Antidepressants

  • Side effects: Common side effects may include nausea, headaches, or sleep changes.  These often improve after the first few weeks. Consult your healthcare provider if these become bothersome or persist.
  • Dependency fears: Antidepressants are non-addictive, but stopping them abruptly can cause withdrawal symptoms, so tapering under medical supervision is important.

Lifestyle and Holistic Interventions

Incorporating lifestyle changes into a treatment plan boosts effectiveness and enhances well-being:

Advanced Treatments for Resistant Cases

For those with treatment-resistant depression, innovative therapies offer new hope:

  • Electroconvulsive Therapy (ECT): ECT uses controlled electrical currents to stimulate brain activity and may help alleviate symptoms in severe cases. Administered under anesthesia, it’s a highly effective option for severe cases, particularly when suicidal ideation is present.
  • Transcranial Magnetic Stimulation (TMS): TMS uses magnetic pulses to stimulate underactive brain regions associated with mood. A typical course involves daily sessions over several weeks, with benefits lasting months or longer.
  • Ketamine Therapy: Low-dose ketamine infusions have emerged as a game-changer for treatment-resistant depression. Unlike traditional antidepressants, ketamine has been shown in some studies to produce effects within hours, though individual results vary.

While treatments are effective, finding the right approach often depends on individual factors.

When and How to Seek Help

Knowing when to seek professional help is a critical step in managing MDD and preventing symptoms from worsening.

Recognizing When It’s Time to Seek Help

Understanding when to seek professional support is vital for managing major depressive disorder. While mild depressive symptoms may improve with self-care, persistent or worsening symptoms often require intervention. Key signs that indicate it’s time to seek help include:

  • Worsening Symptoms: Low mood, fatigue, or hopelessness that continues for more than two weeks and disrupts daily life.
  • Inability to Cope: Feeling overwhelmed by even small tasks, such as cooking or going to work.
  • Physical Symptoms: Unexplained aches, headaches, or gastrointestinal issues that accompany emotional distress.
  • Suicidal Thoughts or Behaviors: If you or someone you know is experiencing thoughts of self-harm or suicide, seek immediate professional help or contact emergency services.

Preparing for Your First Appointment

Attending a mental health consultation can feel intimidating, but preparation helps ensure the best outcomes. Here’s how to prepare:

  1. What to Expect: During a mental health consultation, the provider will ask about your symptoms, medical history, and lifestyle to better understand your situation. This is a safe space to discuss your concerns openly, and the goal is to develop a tailored treatment plan that meets your needs.
  2. Document Symptoms: Keep a journal detailing the frequency, duration, and severity of symptoms. Note specific examples, such as difficulty concentrating at work or avoiding social events.
  3. Questions to ask: Before your appointment, write a list of questions that you may have.  Bring this list to your appointment. Examples include:
    • “What type of therapy do you recommend for me?”
    • “Are medications necessary at this stage of my treatment?”
    • “What lifestyle changes can help improve my symptoms?”
  4. Compile Medical Information: Share a list of current medications, supplements, and any past mental health treatments.

After starting treatment, tracking your progress can guide adjustments and improve outcomes.

Monitoring Progress and Maintaining Recovery

Staying informed about your progress allows you to celebrate improvements, address setbacks early, and make necessary adjustments to your treatment plan.

Tracking Symptoms for Progress

Monitoring progress is essential for evaluating the effectiveness of treatment and identifying areas for improvement. Strategies include:

  • Mood Journals: Write about daily emotions, stressors, and positive moments. This helps patients and providers spot patterns or triggers.
  • Apps for Mental Health: Tools like Daylio and Moodpath may help individuals track symptoms and reflect on emotional well-being.
  • Regular Assessments: Scales like the PHQ-9 can be repeated periodically to measure symptom changes.

Building a Resilient Support Network

Recovery is rarely a solo journey. Having a robust support system fosters resilience and helps prevent isolation. Steps to strengthen a support network include:

  • Engaging with Loved Ones: Regular communication with family and friends can reduce feelings of loneliness.
  • Joining Support Groups: Peer groups, either online or in person, connect individuals who share similar experiences. This sense of community can be deeply validating.
  • Seeking Professional Allies: Maintaining ongoing relationships with mental health professionals ensures access to expertise during setbacks.

Strategies for Preventing Relapse

Preventing relapse involves understanding triggers and adopting proactive habits:

  • Stick to Your Treatment Plan: Medications and therapy often remain essential even after significant improvement.
  • Identify Warning Signs: Examples include fatigue, irritability, or loss of interest in daily activities.
  • Create a Relapse Plan: Work with a provider to outline steps to take if symptoms return, including increasing therapy sessions or medication adjustments.
  • Practice Daily Self-Care: Regular exercise, balanced nutrition, and mindfulness routines bolster emotional stability.

By staying informed and proactive, you can manage MDD effectively.

Although major depressive disorder is challenging, the right treatment can make recovery possible and sustainable. If you or someone you know is struggling with depression, don’t wait to seek help. 

Consulting a mental health professional or reaching out to support networks can be a life-changing step toward recovery. You are not alone, and effective treatments are available to help you feel better.

[signup]

Key Takeaways

  • Major depressive disorder (MDD) is common but treatable.
  • Symptoms: MDD includes physical symptoms like fatigue, appetite changes, and chronic pain, alongside emotional struggles such as hopelessness and loss of interest in activities.
  • Early diagnosis: Recognizing and addressing symptoms early can prevent the condition from worsening and support faster recovery.
  • Treatment Options:
    • Psychotherapy: Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT).
    • Medications, including SSRIs, SNRIs, and atypical antidepressants.
    • Lifestyle changes, like regular exercise, improved nutrition, and mindfulness practices.
  • Advanced therapies for treatment-resistant cases: Options like electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and ketamine infusions may help individuals who have not responded to other treatments.
  • Support systems: Family, friends, and peer groups can provide emotional and practical help during recovery.
  • Monitoring progress: Journaling, mental health apps, and regular therapy sessions can identify triggers and track improvements.
  • Preventing relapse: Recognizing warning signs, adhering to treatment plans, and prioritizing self-care help sustain long-term well-being.

If you or someone you care about is experiencing depression, don’t wait to get help. Talk to a mental health professional, a trusted friend, or a support group. MDD may be challenging, but with appropriate treatment and support, many individuals can manage their symptoms and improve their quality of life.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Beard, C., Hsu, K. J., Rifkin, L. S., Busch, A. B., & Björgvinsson, T. (2016). Validation of the PHQ-9 in a psychiatric sample. Journal of Affective Disorders, 193(193), 267–273. https://doi.org/10.1016/j.jad.2015.12.075

Billiard, M., & Dauvilliers, Y. (2001). Idiopathic Hypersomnia. Sleep Medicine Reviews, 5(5), 349–358. https://doi.org/10.1053/smrv.2001.0168

Burchert, S., Kerber, A., Zimmermann, J., & Knaevelsrud, C. (2021). Screening accuracy of a 14-day smartphone ambulatory assessment of depression symptoms and mood dynamics in a general population sample: Comparison with the PHQ-9 depression screening. PLOS ONE, 16(1), e0244955. https://doi.org/10.1371/journal.pone.0244955

Chi, K. F., Korgaonkar, M., & Grieve, S. M. (2015). Imaging predictors of remission to anti-depressant medications in major depressive disorder. Journal of Affective Disorders, 186, 134–144. https://doi.org/10.1016/j.jad.2015.07.002

Cloyd, J. (2023a, March 7). An integrative medicine approach to fatigue. Retrieved from Rupa Health website: https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue

Cloyd, J. (2023b, April 14). How to alleviate gastrointestinal (GI) symptoms naturally without medication. Retrieved from Rupa Health website: https://www.rupahealth.com/post/how-to-alleviate-gastrointestinal-gi-symptoms-naturally-without-medication

Cloyd, J. (2023c, August 25). A Root Cause Medicine Protocol For Patients With Insomnia: Testing, Therapeutic Diet, and Supportive Supplements. Retrieved from Rupa Health website: https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-insomnia-testing-therapeutic-diet-and-supportive-supplements

Cloyd, J. (2023d, September 25). Integrative Approaches to Supporting Mental Health In Chronic Conditions. Retrieved from Rupa Health website: https://www.rupahealth.com/post/integrative-approaches-to-supporting-mental-health-in-chronic-conditions

Cloyd, J. (2023e, October 13). The Role of Nutrition in Managing Fatigue: Foods that Boost Energy. Retrieved from Rupa Health website: https://www.rupahealth.com/post/the-role-of-nutrition-in-managing-fatigue-foods-that-boost-energy

Cloyd, J. (2024, September 17). Enhancing Psychological Wellbeing Through Exercise: The Role of Self-Esteem. Retrieved from Rupa Health website: https://www.rupahealth.com/post/enhancing-psychological-wellbeing-through-exercise-the-role-of-self-esteem

Cortisol. (n.d.). Retrieved from Rupa Health website: https://www.rupahealth.com/biomarkers/cortisol

DePorto, T. (2023, January 6). Omega 3’s: The Superfood Nutrient You Need To Know About. Retrieved from Rupa Health website: https://www.rupahealth.com/post/omega-3s-the-superfood-nutrient-you-need-to-know-about

Diorio, B. (2023, February 24). The Benefits of Integrative Nutrition: How to Maximize Your Health Through Food. Retrieved from Rupa Health website: https://www.rupahealth.com/post/the-role-of-nutrition-in-integrative-medicine

Dopamine. (n.d.). Retrieved from Rupa Health website: https://www.rupahealth.com/biomarkers/dopamine

Endler, N. S. (1988). The Origins of Electroconvulsive Therapy (ECT). The Journal of ECT, 4(1), 5. Retrieved from https://journals.lww.com/ectjournal/Abstract/1988/04010/The_Origins_of_Electroconvulsive_Therapy__ECT_.3.aspx

Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychotherapy and Psychosomatics, 84(2), 72–81. https://doi.org/10.1159/000370338

Henry, E. (2021, July 16). A Functional Medicine Approach to Thyroid Hormone Labs. Retrieved from www.rupahealth.com website: https://www.rupahealth.com/post/a-functional-medicine-approach-to-thyroid-hormone-labs

Hetrick, S. E., Cox, G. R., Witt, K. G., Bir, J. J., & Merry, S. N. (2016). Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents. Cochrane Database of Systematic Reviews, 8(8). https://doi.org/10.1002/14651858.cd003380.pub4

Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012). The Efficacy of Cognitive Behavioral Therapy: a Review of Meta-Analyses. Cognitive Therapy and Research, 36(5), 427–440. https://doi.org/10.1007/s10608-012-9476-1

Horst, W. Dale., & Preskorn, S. H. (1998). Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Journal of Affective Disorders, 51(3), 237–254. https://doi.org/10.1016/s0165-0327(98)00222-5

Hussain, A., Mkpojiogu, E., Hussein, I., Muhi, O., Hibatul, M., & Yosri, H. (2020). The Effectiveness, Efficiency and Reliability-in-Use of Daylio Mobile App chaining in the context of Software defined networking View project Usability Testing for Low Income Earners (B40) User Segment View project The Effectiveness, Efficiency and Reliability-in-Use of Daylio Mobile App. International Journal of Advanced Science and Technology, 29(8), 180–187. Retrieved from https://onemindpsyberguide.org/guide/files/pdf/5ed645c145851529452824ac/the-effectiveness-efficiency-and-reliability-in-use-of-daylio-mobile-app.pdf

Hyttel, J. (1994). Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). International Clinical Psychopharmacology, 9, 19–26. Retrieved from https://journals.lww.com/intclinpsychopharm/Abstract/1994/03001/Pharmacological_characterization_of_selective.4.aspx

Iron. (n.d.). Retrieved from Rupa Health website: https://www.rupahealth.com/biomarkers/iron

Jakubovski, E., Varigonda, A. L., Freemantle, N., Taylor, M. J., & Bloch, M. H. (2016). Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. American Journal of Psychiatry, 173(2), 174–183. https://doi.org/10.1176/appi.ajp.2015.15030331

Kazdin, A. E. (2009). Understanding how and why psychotherapy leads to change. Psychotherapy Research, 19(4-5), 418–428. https://doi.org/10.1080/10503300802448899

Klengel, T., & Binder, E. B. (2013). Gene—Environment Interactions in Major Depressive Disorder. The Canadian Journal of Psychiatry, 58(2), 76–83. https://doi.org/10.1177/070674371305800203

Klomjai, W., Katz, R., & Lackmy-Vallée, A. (2015). Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Annals of Physical and Rehabilitation Medicine, 58(4), 208–213. https://doi.org/10.1016/j.rehab.2015.05.005

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x

Kupfer, D. J., Frank, E., & Phillips, M. L. (2012). Major depressive disorder: new clinical, neurobiological, and treatment perspectives. The Lancet, 379(9820), 1045–1055. https://doi.org/10.1016/s0140-6736(11)60602-8

Longmore, R. J., & Worrell, M. (2007). Do we need to challenge thoughts in cognitive behavior therapy? Clinical Psychology Review, 27(2), 173–187. https://doi.org/10.1016/j.cpr.2006.08.001

Ma, C.-L., Ma, X.-T., Wang, J.-J., Liu, H., Chen, Y.-F., & Yang, Y. (2017). Physical exercise induces hippocampal neurogenesis and prevents cognitive decline. Behavioural Brain Research, 317, 332–339. https://doi.org/10.1016/j.bbr.2016.09.067

Maholy, N. (2023, June 15). The Role Of Sleep And Circadian Rhythms In Neurological Health. Retrieved from Rupa Health website: https://www.rupahealth.com/post/the-role-of-sleep-and-circadian-rhythms-in-neurological-health

Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023). Major depressive disorder. Nature Reviews Disease Primers, 9(1). https://doi.org/10.1038/s41572-023-00454-1

Morgan, C. J. A., & Curran, H. V. (2011). Ketamine use: a review. Addiction, 107(1), 27–38. https://doi.org/10.1111/j.1360-0443.2011.03576.x

Neibling, K. (2023, February 27). Integrative medicine treatment for headaches. Retrieved from Rupa Health website: https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches

Norepinephrine. (n.d.). Retrieved from Rupa Health website: https://www.rupahealth.com/biomarkers/norepinephrine

Panos, P. T., Jackson, J. W., Hasan, O., & Panos, A. (2014). Meta-Analysis and Systematic Review Assessing the Efficacy of Dialectical Behavior Therapy (DBT). Research on Social Work Practice, 24(2), 213–223. https://doi.org/10.1177/1049731513503047

Preston, J. (2023, September 29). How to Balance Hormones After Pregnancy: A Comprehensive Guide. Retrieved from Rupa Health website: https://www.rupahealth.com/post/how-to-balance-hormones-after-pregnancy-a-comprehensive-guide

Regier, D. A., Kuhl, E. A., & Kupfer, D. J. (2013). The DSM-5: Classification and criteria changes. World Psychiatry, 12(2), 92–98. https://doi.org/10.1002/wps.20050

Rizvi, S. J., Pizzagalli, D. A., Sproule, B. A., & Kennedy, S. H. (2016). Assessing anhedonia in depression: Potentials and pitfalls. Neuroscience & Biobehavioral Reviews, 65, 21–35. https://doi.org/10.1016/j.neubiorev.2016.03.004

Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2015). The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. International Journal of Neuropsychopharmacology, 19(2), pyv082. https://doi.org/10.1093/ijnp/pyv082

Serotonin. (n.d.). Retrieved from Rupa Health website: https://www.rupahealth.com/biomarkers/serotonin

Stahl, S. M., Grady, M. M., Moret, C., & Briley, M. (2005). SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants. CNS Spectrums, 10(9), 732–747. https://doi.org/10.1017/s1092852900019726

Stanford, J. (2024, August 7). Whole Grains 101: A Guide to Nutritious Choices. Retrieved from Rupa Health website: https://www.rupahealth.com/post/whole-grains-101-a-guide-to-nutritious-choices

Sweetnich, J. (2023a, March 6). The Ultimate Guide to Hypothyroidism Lab Testing. Retrieved from Rupa Health website: https://www.rupahealth.com/post/the-ultimate-guide-to-hypothyroidism-lab-testing

Sweetnich, J. (2023b, June 12). Integrative Treatment Options for Adrenal Disorders: Specialty Testing, Nutrition, Supplements. Retrieved from Rupa Health website: https://www.rupahealth.com/post/integrative-treatment-options-for-adrenal-disorders-specialty-testing-nutrition-supplements

Sweetnich, J. (2023c, June 30). Top 5 Antioxidants That Can Improve Your Health and How To Test Your Patient’s Levels. Retrieved from Rupa Health website: https://www.rupahealth.com/post/top-5-antioxidants-to-improve-your-health

Teeter, L. A. (2023, April 3). Mental health benefits of yoga and meditation. Retrieved from Rupa Health website: https://www.rupahealth.com/post/mental-health-benefits-of-yoga-and-meditation

Valjent, E., Pages, C., Herve, D., Girault, J.-A., & Caboche, J. (2004). Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. European Journal of Neuroscience, 19(7), 1826–1836. https://doi.org/10.1111/j.1460-9568.2004.03278.x

Vitamin D. (n.d.). Retrieved from Rupa Health website: https://www.rupahealth.com/biomarkers/vitamin-d

Wai, J. M., Shulman, M., Nunes, E. V., Hasin, D. S., & Weiss, R. D. (2020). Co-occurring Mood and Substance Use Disorders. Springer EBooks, 1297–1313. https://doi.org/10.1007/978-3-030-36391-8_91

Wakefield, J. C. (2013). DSM-5: An Overview of Changes and Controversies. Clinical Social Work Journal, 41(2), 139–154. https://doi.org/10.1007/s10615-013-0445-2

Yan, G., Zhang, Y., Wang, S., Yan, Y., Liu, M., Tian, M., & Tian, W. (2024). Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: An analysis of the global burden of disease study. Psychiatry Research, 337, 115958. https://doi.org/10.1016/j.psychres.2024.115958

Yoshimura, H. (2023a, September 6). Top Labs To Run Bi-Annually On Your Patients Who Suffer From Major Depressive Disorder. Retrieved from Rupa Health website: https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-major-depressive-disorder

Yoshimura, H. (2023b, November 7). The remarkable power of exercise on our health: A comprehensive overview. Retrieved from Rupa Health website: https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Mental Health
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.